ZYNERBA PHARMACEUTICALS, INC. Defined Contribution Plan, Cost
ZYNERBA PHARMACEUTICALS, INC. reported Defined Contribution Plan, Cost of $240.83 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2023-03-28
- ZYNERBA PHARMACEUTICALS, INC. defined contribution plan, cost for the quarter ending 2018-03-31 was $21.12K.
- ZYNERBA PHARMACEUTICALS, INC. defined contribution plan, cost for the quarter ending 2017-03-31 was $0.00.
- ZYNERBA PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2022 was $240.83K, a 116.46% increase from fiscal 2021.
- ZYNERBA PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2021 was $111.26K, a 0.53% decline from fiscal 2020.
- ZYNERBA PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2020 was $111.85K, a 4.12% increase from fiscal 2019.
- ZYNERBA PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2019 was $107.42K, a 27.46% increase from fiscal 2018.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|
| 2022-12-31 | $240.83K 10-K · filed 2023-03-28 | |
| 2021-12-31 | $111.26K 10-K · filed 2023-03-28 | |
| 2020-12-31 | $111.85K 10-K · filed 2023-03-28 | |
| 2019-12-31 | $107.42K 10-K · filed 2022-03-01 | |
| 2018-12-31 | $84.28K 10-K · filed 2021-03-10 | |
| 2018-03-31 | $21.12K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $0.00 10-K · filed 2020-03-10 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | |
| 2016-12-31 | $0.00 10-K · filed 2019-03-11 |